PIPR:NYSEPiper Sandler Companies Analysis
Data as of 2026-04-24 - not real-time
$86.79
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Piper Sandler is trading at $86.79, comfortably above its 20‑day (≈$83.48) and 50‑day (≈$78.81) SMAs and showing a bullish MACD histogram, while the RSI sits near 61, indicating modest momentum.
The firm delivers exceptional top‑line growth of roughly 38% YoY, ultra‑high gross margins (≈90%) and solid operating margins (≈30%), supporting a forward‑PE of about 15 versus a trailing‑PE of 22, which is higher than the industry average of 17.3.
Despite a high beta (~1.6) and 30‑day volatility near 26%, the balance sheet is strong with over $1.3 bn of cash, low debt levels, and a sustainable dividend (0.8% yield, 17% payout), giving the stock an upside of roughly 9% to consensus target prices and a compelling DCF‑derived fair value far above current levels.
The firm delivers exceptional top‑line growth of roughly 38% YoY, ultra‑high gross margins (≈90%) and solid operating margins (≈30%), supporting a forward‑PE of about 15 versus a trailing‑PE of 22, which is higher than the industry average of 17.3.
Despite a high beta (~1.6) and 30‑day volatility near 26%, the balance sheet is strong with over $1.3 bn of cash, low debt levels, and a sustainable dividend (0.8% yield, 17% payout), giving the stock an upside of roughly 9% to consensus target prices and a compelling DCF‑derived fair value far above current levels.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD and price above short‑term moving averages
- Decreasing volume trend suggesting reduced short‑term participation
- Neutral technical trend direction with modest upside to resistance
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong revenue growth (~38%) and high operating margins
- Upside of ~9% to analyst consensus target and undervaluation relative to DCF
- Sustainable dividend with low payout ratio and ample cash reserves
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Robust capital structure (high cash, modest debt) and low leverage
- Consistent profitability (ROE ~20%) and attractive forward earnings multiple
- Long‑term growth opportunities in capital‑markets advisory and asset management
Key Metrics & Analysis
Financial Health
Revenue Growth37.60%
Profit Margin14.81%
P/E Ratio21.9
ROE19.61%
ROA12.13%
Debt/Equity7.46
P/B Ratio4.3
Op. Cash Flow$586.6M
Industry P/E17.3
Technical Analysis
TrendNeutral
RSI60.7
Support$72.48
Resistance$93.06
MA 20$83.48
MA 50$78.81
MA 200$83.21
MACDBullish
VolumeDecreasing
Fear & Greed Index88.02
Valuation
Fair Value$229.11
Target Price$94.88
Upside/Downside9.32%
GradeUndervalued
TypeBlend
Dividend Yield0.80%
Risk Assessment
Beta1.67
Volatility25.99%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.